e-learning
resources
Berlin 2008
Monday, 06.10.2008
Border patrol: the alveolar barrier in lung injury
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Alveolar recruited macrophages contribute to lung epithelial apoptosis and barrier dysfunction by expression of TNF-related apoptosis-inducing ligand during influenza virus pneumonia
S. Herold, M. Steinmueller, W. von Wulffen, L. Cakarova, S. Pleschka, W. Seeger, J. Lohmeyer (Giessen, Germany)
Source:
Annual Congress 2008 - Border patrol: the alveolar barrier in lung injury
Session:
Border patrol: the alveolar barrier in lung injury
Session type:
E-Communication Session
Number:
1676
Disease area:
Respiratory infections
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
S. Herold, M. Steinmueller, W. von Wulffen, L. Cakarova, S. Pleschka, W. Seeger, J. Lohmeyer (Giessen, Germany). Alveolar recruited macrophages contribute to lung epithelial apoptosis and barrier dysfunction by expression of TNF-related apoptosis-inducing ligand during influenza virus pneumonia. Eur Respir J 2008; 32: Suppl. 52, 1676
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Management of severe community acquired pneumonia – ERS guidelines
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Predictive indexes in prolonged weaning of mechanical ventilation due to tracheostomy in patients with COVID-19 pneumonia
Related content which might interest you:
Macrophage released TNF-related apoptosis-inducing ligand (TRAIL) impairs alveolar fluid clearance after Influenza A virus infection
Source: Lung Science Conference 2015
Year: 2015
The role of TNF-related apoptosis inducing ligand (TRAIL) in fibrotic lung disease
Source: Annual Congress 2011 - Growth factors and fibrogenesis: are they good, bad or both?
Year: 2011
Role of TNF-related apoptosis inducing ligand (TRAIL) in lung protective immunity against
S. pneumoniae
Source: Annual Congress 2010 - Mechanisms of respiratory infections
Year: 2010
Fas activation impairs the alveolar epithelial function in mice by mechanisms involving apoptosis
Source: Annual Congress 2011 - Anti-inflammatory strategies in acute lung injury
Year: 2011
Fas Ligand (FasL) expressed on alveolar lymphocytes (AL) plays role in progression of interstitial lung diseases (ILD) but not in local induction of immune cells apoptosis
Source: Eur Respir J 2005; 26: Suppl. 49, 542s
Year: 2005
TNF-mediated alveolar macrophage necroptosis drives disease pathogenesis during respiratory syncytial virus infection
Source: Eur Respir J, 57 (6) 2003764; 10.1183/13993003.03764-2020
Year: 2021
RSV infection induces MDC production in respiratory epithelial cells
Source: Eur Respir J 2004; 24: Suppl. 48, 482s
Year: 2004
Resistance to Fas-mediated apoptosis in human lung fibroblast
Source: Eur Respir J 2002; 20: 359-368
Year: 2002
Enhanced expression of Fas ligand (FasL) in fibrotic interstitial lung diseases (ILDs). The possible role of membrane-bound FasL form
Source: Annual Congress 2011 - Genetic and molecular background in pulmonary fibrosis
Year: 2011
Activation of Fas receptor impairs alveolar epithelial function in mouse lungs
Source: Annual Congress 2010 - Emerging mechanisms in lung injury
Year: 2010
Kaempferol-induced HO-1 expression attenuated inflammation in human pulmonary alveolar epithelial cells
Source: International Congress 2017 – Therapeutic approaches in lung disease
Year: 2017
Mesenchymal stem cells reduce lung metastases by controlled targeted delivery of TNF-related apoptosis-inducing ligand (TRAIL)
Source: Annual Congress 2009 - Diagnosis and treatment of lung cancer
Year: 2009
Resident alveolar macrophages mediate early alveolar epithelial death signaling and dysfunction
Source: Annual Congress 2012 - Novel mechanisms of acute lung injury
Year: 2012
Fas-mediated lung injury is independent of resident alveolar macrophages
Source: Eur Respir J 2007; 30: Suppl. 51, 444s
Year: 2007
Role of alveolar epithelial ICAM-1 in lipopolysaccharide-induced lung inflammation
Source: Eur Respir J 2002; 19: 1142-1150
Year: 2002
The NS1A binding protein in alveolar epithelial cells as centerpiece of Influenza virus A lung injury mechanism mediated via AhR/Arnt signaling pathway
Source: International Congress 2017 – Anti-inflammatory and pro-repair mediators in acute lung injury
Year: 2017
Upregulation of the production of TGF-β and IL-4 and downregulation of IL-6 by apoptotic human bronchial epithelial cells: possible role in regulation of epithelial repair following acute lung injury
Source: Eur Respir J 2001; 18: Suppl. 33, 477s
Year: 2001
Rhinovirus infection reduces glucocorticoid receptor nuclear translocation in airway epithelial cells
Source: Annual Congress 2003 - Acute exacerbations of asthma and COPD
Year: 2003
Human rhinovirus causes increase in angiogenetic activity of lung endothelial cells – potential involvement in enhanced vasculature in asthmatics
Source: Virtual Congress 2021 – Environmental and lifestyle impacts on chronic lung disease
Year: 2021
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept